Goodwill of Amphastar Pharmaceuticals, Inc. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Amphastar Pharmaceuticals, Inc. Goodwill for the quarter ending 30 Sep 2025 was $3,404,000, a 4.5% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Amphastar Pharmaceuticals, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,404,000 +$148,000 +4.5% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $3,397,000 +$268,000 +8.6% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,157,000 +$5,000 +0.16% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $3,049,000 -$167,000 -5.2% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $3,256,000 +$164,000 +5.3% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $3,129,000 -$36,000 -1.1% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $3,152,000 -$23,000 -0.72% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $3,216,000 +$90,000 +2.9% 31 Dec 2023 10-Q 06 Nov 2025 2025 Q3
Q3 2023 $3,092,000 +$206,000 +7.1% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $3,165,000 +$111,000 +3.6% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,175,000 -$81,000 -2.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $3,126,000 -$187,000 -5.6% 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $2,886,000 -$500,000 -15% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $3,054,000 -$786,000 -20% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $3,256,000 -$537,000 -14% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $3,313,000 -$627,000 -16% 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $3,386,000 -$387,000 -10% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $3,840,000 +$207,000 +5.7% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,793,000 +$222,000 +6.2% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $3,940,000 +$306,000 +8.4% 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $3,773,000 -$13,000 -0.34% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $3,633,000 -$297,000 -7.6% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $3,571,000 -$324,000 -8.3% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $3,634,000 -$317,000 -8% 31 Dec 2019 10-K 11 Mar 2022 2021 FY
Q3 2019 $3,786,000 -$211,000 -5.3% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $3,930,000 -$431,000 -9.9% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $3,895,000 -$688,000 -15% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $3,951,000 -$510,000 -11% 31 Dec 2018 10-K 15 Mar 2021 2020 FY
Q3 2018 $3,997,000 -$404,000 -9.2% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $4,361,000 +$90,000 +2.1% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $4,583,000 +$552,000 +14% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $4,461,000 +$485,000 +12% 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $4,401,000 +$191,000 +4.5% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $4,271,000 +$112,000 +2.7% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $4,031,000 -$290,000 -6.7% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $3,976,000 +$250,000 +6.7% 31 Dec 2016 10-K 15 Mar 2019 2018 FY
Q3 2016 $4,210,000 +$378,000 +9.9% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $4,159,000 +$374,000 +9.9% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $4,321,000 +$613,000 +17% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 $3,726,000 -$741,000 -17% 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $3,832,000 -$817,000 -18% 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 $3,785,000 +$3,505,000 +1252% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 $3,708,000 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 $4,467,000 +$4,187,000 +1495% 31 Dec 2014 10-K 15 Mar 2017 2016 FY
Q3 2014 $4,649,000 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 $280,000 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q4 2013 $280,000 $0 0% 31 Dec 2013 10-K 15 Mar 2016 2015 FY
Q4 2012 $280,000 31 Dec 2012 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.